Gemtuzumab ozogamicin, an antibody–drug conjugate is also a progressive medication to treat leukemia patients. Predominantly identified for its effectiveness as a treatment option in the management of acute myeloid leukemia,…
Author: Medinfo
Clinical practice of Polivy and the best way to procure Polatuzumab in India
Polatuzumab is an IV medication approved by FDA has been prescribed by Hematologists in the recent times. It’s approval as a therapeutic option for the management of diffuse large B-cell…
Besponsa in India; Inotuzumab and its recommendations for ALL management
Inotuzumab is a monoclonal antibody administered in combination of chemotherapy drugs. This is advised as a therapeutic option in adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia….
Eculizumab in India; Soliris for the treatment of Emergency Medical Conditions
Eculizumab is FDA drug approved for the management of various critical conditions including neuromyelitis optic. Soliris is also recommended as a drug of choice for the treatment of paroxysmal nocturnal…
Growing relevance of Elotuzumab in India – Empliciti for Multiple myeloma
Elotuzumab is an upcoming FDA drug, prescribed for the management of multiple myeloma, one of the complex malignances treated by Hematologists. The commercial reference to Elotuzumab is Empliciti, a brand…